These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 2407484)
1. [Low-dose enalapril as additional medication in severe chronic heart failure]. Brilla C; Krämer B; Hoffmeister HM; Müller-Schauenburg W; Risler T; Seipel L Dtsch Med Wochenschr; 1990 Feb; 115(8):283-9. PubMed ID: 2407484 [TBL] [Abstract][Full Text] [Related]
2. [Low-dose enalapril in severe chronic heart failure]. Brilla CG; Krämer B; Risler T; Seipel L Z Kardiol; 1991; 80 Suppl 2():44-9. PubMed ID: 2024542 [TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
4. Enalapril in chronic heart failure, a double-blind placebo-controlled study. Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174 [TBL] [Abstract][Full Text] [Related]
5. [Short- and long-term effects of enalapril on the left ventricular function in patients with congestive heart insufficiency]. Traina M; Rotolo A; Trapani R; Messina L; Candela B; Mercurio G; Raineri A Cardiologia; 1990 Jan; 35(1):55-60. PubMed ID: 2376053 [TBL] [Abstract][Full Text] [Related]
6. Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure. Pomini G; Gribaldo R; Rugna A; Lupia M; Molfese G; Carenza P G Ital Cardiol; 1991 Jan; 21(1):59-65. PubMed ID: 2055378 [TBL] [Abstract][Full Text] [Related]
7. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [TBL] [Abstract][Full Text] [Related]
8. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII]. Dessì-Fulgheri P; Paci MV; Rappelli A Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure. Sasaki T; Kubo T; Komamura K; Nishikimi T J Cardiol; 1999 Jun; 33(6):317-25. PubMed ID: 10396705 [TBL] [Abstract][Full Text] [Related]
11. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group. Johnson G; Carson P; Francis GS; Cohn JN Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of enalapril and captopril in the treatment of chronic heart failure]. Tjon-A-Meeuw L; Hess OM; Greminger P; Maire R; Jenni R; Krayenbuehl HP Z Kardiol; 1990 Jun; 79(6):429-35. PubMed ID: 2198731 [TBL] [Abstract][Full Text] [Related]
13. The effect of enalapril on cardiac arrhythmias in patients with congestive heart failure. Sniezek-Maciejewska M; Czarnecka D; Mroczek-Czernecka D; Kawecka-Jaszcz K Cor Vasa; 1992; 34(5-6):382-9. PubMed ID: 1285055 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580 [TBL] [Abstract][Full Text] [Related]
15. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260 [TBL] [Abstract][Full Text] [Related]
16. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure. Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900 [TBL] [Abstract][Full Text] [Related]
17. Enalapril for severe congestive heart failure. A double-blind study. Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995 [TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599 [TBL] [Abstract][Full Text] [Related]
19. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure]. Vizir VA; Berezin AE Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061 [TBL] [Abstract][Full Text] [Related]
20. First clinical trial with etomoxir in patients with chronic congestive heart failure. Schmidt-Schweda S; Holubarsch C Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]